Variceal bleeding and portal hypertension

Area of Science:

• Gastroenterology
• Hepatology
• Interventional Radiology

Background:

• Variceal bleeding management has evolved significantly over 50 years.
• Pharmacological therapy with beta-blockers is established for primary prevention.
• Endoscopic and radiological interventions offer diverse treatment options.

Purpose of the Study:

• To review current and emerging treatment strategies for variceal bleeding.
• To evaluate the efficacy and limitations of various therapeutic modalities.
• To explore the potential role of new diagnostic and interventional techniques.

Main Methods:

• Review of pharmacological therapies (beta-blockers, octreotide).
• Analysis of endoscopic procedures (band ligation, sclerotherapy).
• Evaluation of radiological interventions (TIPS, balloon-occluded retrograde transvenous obliteration) and investigational tools (endoscopic ultrasound).

Main Results:

• Beta-blockers are effective for primary prophylaxis; adding vasodilators requires further study.
• Band ligation is popular but shows no advantage over beta-blockers for primary prophylaxis and has high recurrence rates.
• Octreotide is validated for preventing rebleeding; Histoacryl is preferred for gastric varices, with band ligation as an alternative.
• Transjugular intrahepatic portosystemic shunt (TIPS) improves survival but is limited by cost and complications.
• Endoscopic ultrasound shows potential for guiding treatment selection.

Conclusions:

• Variceal bleeding treatment is multifaceted, with established and emerging options.
• Beta-blockers remain a cornerstone for primary prevention.
• Further research is needed for combination therapies and the role of novel techniques like endoscopic ultrasound.